These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38109334)

  • 1. The IMPACT (Infection Management Plus Addiction Care Together) Pilot: A Case Series of Combined Contingency Management for Substance Use Disorders and Antibiotic Adherence in the Hospital Setting.
    Appa A; Baral S; Stein B; Knight K; Gandhi M; Coffin P; Martin M
    J Addict Med; 2024 Mar-Apr 01; 18(2):138-143. PubMed ID: 38109334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Acute Care Contingency Management Program for the Treatment of Stimulant Use Disorder: A Case Report.
    Bach P; Garrod E; Robinson K; Fairbairn N
    J Addict Med; 2020 Dec; 14(6):510-513. PubMed ID: 32142054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying behavioral activation to sustain and enhance the effects of contingency management for reducing stimulant use among individuals with HIV infection.
    Mimiaga MJ; Closson EF; Pantalone DW; Safren SA; Mitty JA
    Psychol Health Med; 2019 Mar; 24(3):374-381. PubMed ID: 30211620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.
    Johnson S; Rains LS; Marwaha S; Strang J; Craig T; Weaver T; McCrone P; King M; Fowler D; Pilling S; Marston L; Omar RZ; Craig M; Spencer J; Hinton M
    Health Technol Assess; 2019 Aug; 23(45):1-108. PubMed ID: 31460865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility, Engagement, and Usability of a Remote, Smartphone-Based Contingency Management Program as a Treatment Add-On for Patients Who Use Methamphetamine: Single-Arm Pilot Study.
    Hallgren KA; Duncan MH; Iles-Shih MD; Cohn EB; McCabe CJ; Chang YM; Saxon AJ
    JMIR Form Res; 2023 Jul; 7():e47516. PubMed ID: 37410529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contingency Management for Integrated Harm Reduction Among Men Who Have Sex with Men Who Use Methamphetamine in Los Angeles: A Pilot Assessment.
    Blair CS; Gandhi M; Shoptaw S; Blades C; Clark JL
    AIDS Behav; 2023 Jun; 27(6):1962-1971. PubMed ID: 36414775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spending money to make change: Association of methamphetamine abstinence and voucher spending among contingency management pilot participants in South Africa.
    Krishnamurti T; Ling Murtaugh K; Van Nunen L; Davis AL; Ipser J; Shoptaw S
    J Subst Abuse Treat; 2020 May; 112():60-67. PubMed ID: 32199547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Care-engaged individuals with polysubstance use in Northeastern US are undertreated for methamphetamine use disorder: a retrospective cohort study.
    Yen Li M; Alba GA; Mitton J; Bearnot B
    Addict Sci Clin Pract; 2021 Sep; 16(1):57. PubMed ID: 34565489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signals of increasing co-use of stimulants and opioids from online drug forum data.
    Sarker A; Al-Garadi MA; Ge Y; Nataraj N; Jones CM; Sumner SA
    Harm Reduct J; 2022 May; 19(1):51. PubMed ID: 35614501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI Team.
    Serota DP; Tookes HE; Hervera B; Gayle BM; Roeck CR; Suarez E; Forrest DW; Kolber MA; Bartholomew TS; Rodriguez AE; Doblecki-Lewis S
    Ann Med; 2021 Dec; 53(1):1960-1968. PubMed ID: 34726095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance use patterns, sociodemographics, and health profiles of harm reduction service recipients in Burlington, Vermont.
    Erath TG; LaCroix R; O'Keefe E; Higgins ST; Rawson RA
    Harm Reduct J; 2024 Apr; 21(1):76. PubMed ID: 38580997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contingency Management for Patients Receiving Medication for Opioid Use Disorder: A Systematic Review and Meta-analysis.
    Bolívar HA; Klemperer EM; Coleman SRM; DeSarno M; Skelly JM; Higgins ST
    JAMA Psychiatry; 2021 Oct; 78(10):1092-1102. PubMed ID: 34347030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel combination HIV prevention strategy: post-exposure prophylaxis with contingency management for substance abuse treatment among methamphetamine-using men who have sex with men.
    Landovitz RJ; Fletcher JB; Inzhakova G; Lake JE; Shoptaw S; Reback CJ
    AIDS Patient Care STDS; 2012 Jun; 26(6):320-8. PubMed ID: 22680280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding access to treatment for stimulant use disorder in a frontier state: A qualitative study of contingency management and TRUST program implementation in Montana.
    Green B; Parent S; Ware J; Hasson AL; McDonell M; Nauts T; Collins M; Kim F; Rawson R
    J Subst Use Addict Treat; 2023 Aug; 151():209032. PubMed ID: 37061191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive Medication Management and Contingency Management to enhance adherence to acamprosate for alcohol dependence: the ADAM trial RCT.
    Donoghue K; Boniface S; Brobbin E; Byford S; Coleman R; Coulton S; Day E; Dhital R; Farid A; Hermann L; Jordan A; Kimergård A; Koutsou ML; Lingford-Hughes A; Marsden J; Neale J; O'Neill A; Phillips T; Shearer J; Sinclair J; Smith J; Strang J; Weinman J; Whittlesea C; Widyaratna K; Drummond C
    Health Technol Assess; 2023 Oct; 27(22):1-88. PubMed ID: 37924307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use-Associated Infective Endocarditis.
    Adams JW; Savinkina A; Hudspeth JC; Gai MJ; Jawa R; Marks LR; Linas BP; Hill A; Flood J; Kimmel S; Barocas JA
    JAMA Netw Open; 2022 Feb; 5(2):e220541. PubMed ID: 35226078
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.